Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of AGM

29th Dec 2022 18:10

RNS Number : 2555L
Genedrive PLC
29 December 2022
 

genedrive plc

("genedrive" or the "Company")

 

Result of AGM

 

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held today, all resolutions proposed were duly passed.

 

For information, details of the proxy voting are shown below:

 

Resolutions

Votes For

Vote For (as % of votes cast)

Votes Against

Votes Against (as % of votes cast)

Vote Withheld

1

9,314,654

95.9%

396,009

4.1%

749,665

2

8,398,949

82.0%

1,847,623

18.0%

213,756

3

7,804,248

79.2%

2,045,968

20.8%

610,112

4

7,804,248

79.9%

1,958,332

20.1%

697,748

5

6,887,924

68.5%

3,165,195

31.5%

407,209

6

6,474,868

74.7%

2,193,549

25.3%

1,791,911

7

8,676,922

88.1%

1,173,294

11.9%

610,112

8

8,646,108

93.4%

608,071

6.6%

1,206,149

9

8,031,215

84.1%

1,515,314

15.9%

913,799

10

7,205,751

75.3%

2,357,879

24.7%

896,698

 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.genedriveplc.com).

 

Although all the resolutions were passed, the Board of genedrive notes that more than 20% of votes were cast against the reappointment of certain directors and the resolution to generally disapply pre-emption rights (subject to certain limits). While the Board believes that all these directors bring considerable experience and expertise to the Board, it intends to engage with shareholders to better understand their concerns on the resolutions.

 

For further details please contact:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth 

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & IR)

+44 (0)20 7933 8780 or [email protected]

Paul McManus / Anna Dunphy

+44 (0)7980 541 893

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBIBDDLGDDGDC

Related Shares:

Genedrive
FTSE 100 Latest
Value8,837.91
Change26.87